Haleon (HLN)

Sector:

Pharma and Biotech

Index:

FTSE 100

331.50p
   
  • Change Today:
      1.90p
  • 52 Week High: 353.00
  • 52 Week Low: 308.55
  • Currency: UK Pounds
  • Shares Issued: 9,132m
  • Volume: 17,967,217
  • Market Cap: £30,274m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
18-Apr-24 HSBC Buy 321.20p - - New Coverage
09-Apr-24 Barclays Overweight 322.30p 390.00p 383.00p Reiteration
06-Nov-23 Barclays Overweight 322.75p 367.00p 391.00p Reiteration
10-Oct-23 JP Morgan Cazenove Underweight 340.00p - 280.00p Reiteration
12-Apr-23 Barclays Overweight 345.75p 364.00p 383.00p Reiteration
06-Mar-23 Jefferies Hold 317.00p 335.00p 330.00p Reiteration
01-Feb-23 JP Morgan Cazenove Underweight 318.55p - 250.00p Reiteration
31-Jan-23 Barclays Overweight 324.25p 360.00p 364.00p Reiteration
25-Jan-23 Credit Suisse Outperform 314.05p - 376.00p Reiteration
08-Dec-22 Deutsche Hold 316.15p 300.00p 300.00p Reiteration
07-Dec-22 Barclays Overweight 305.70p 289.00p 360.00p DownGrade
14-Nov-22 Deutsche Hold 281.85p 300.00p 300.00p Reiteration
14-Nov-22 Barclays Overweight 281.85p 850.00p 890.00p Reiteration
11-Nov-22 Barclays Equal-weight 277.50p 298.00p 298.00p Reiteration
21-Sep-22 Deutsche Hold 267.60p 300.00p 300.00p Reiteration
21-Sep-22 JP Morgan Cazenove Underweight 267.60p 250.00p 250.00p Reiteration
09-Sep-22 Deutsche Hold 261.00p 300.00p 300.00p Reiteration
07-Sep-22 JP Morgan Cazenove Underweight 255.00p 280.00p 250.00p Reiteration
16-Aug-22 RBC Capital Markets Sector perform 269.10p 300.00p 300.00p Reiteration
11-Aug-22 JP Morgan Cazenove Underweight 265.80p 280.00p 280.00p Reiteration
21-Jul-22 Citigroup Buy 314.20p 360.00p 360.00p Reiteration
19-Jul-22 Barclays Equal-weight 301.00p - 348.00p Upgrade
19-Jul-22 Credit Suisse Outperform 301.00p 368.00p 368.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Haleon Market Data

Currency UK Pounds
Share Price 331.50p
Change Today 1.90p
% Change 0.58 %
52 Week High 353.00
52 Week Low 308.55
Volume 17,967,217
Shares Issued 9,132m
Market Cap £30,274m

Haleon Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.19% above the market average13.19% above the market average13.19% above the market average13.19% above the market average13.19% above the market average
77.36% above the sector average77.36% above the sector average77.36% above the sector average77.36% above the sector average77.36% above the sector average
Price Trend
7.8% below the market average7.8% below the market average7.8% below the market average7.8% below the market average7.8% below the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average
Income
3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average

Haleon Dividends

  Latest Previous
  Final Interim
Ex-Div 14-Mar-24 24-Aug-23
Paid 16-May-24 05-Oct-23
Amount 4.20p 1.80p

Trades for 25-Apr-2024

Time Volume / Share Price
16:36 4,358 @ 331.50p
16:35 205 @ 331.50p
16:35 5,979,177 @ 331.50p
16:35 499 @ 331.50p
16:35 3,258 @ 331.50p

Haleon Key Personnel

CFO Tobias Hestler
CEO Brian McNamara

Top of Page